Almirall - Crunchbase Company Profile & Funding

Q: Where is Almirall's headquarters?

Almirall is located in Barcelona, Catalonia, Spain.

Q: When was the last funding round for Almirall?

Almirall closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Almirall raised to date?

Almirall has raised obfuscated.

Overview

Almirall

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Almirall

CB Rank

50837

Almirall is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain.

Founded

obfuscation

Public

Post-IPO Equity

Barcelona, Catalonia, Spain

1001-5000

almirall.com

Biotechnology

Medical Device

Pharmaceutical

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Key People

Antonio Gallardo Carreras: Co-Founder & CEO
Silvia López: Corporate Finance Manager, Head of Department

Details

Legal Name

Almirall, S.A

Operating Status

Active

Stock Symbol

BME:ALM

Company Type

For Profit

Founders

Antonio Gallardo Carreras

About the Company

Almirall is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain. The company researches, develops, manufactures and commercialises its own R&D and licensed drugs with the aim of improving people’s health and wellbeing.

Phone Number

(349) 329-1300

Contact Email

comercial@almirall.com

Predictions & Insights

Growth Insight

See this Growth Insight

Almirall is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Products & Services

Skilarence

A topical gel used to treat moderate to severe plaque psoriasis by reducing skin inflammation and scaling.

Siliq (Brodalumab)

An injectable medication for adults with moderate to severe plaque psoriasis that blocks specific immune system proteins to reduce symptoms.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Almirall	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation
obfuscated obfuscation	Ancora.ai	—	Grant - Ancora.ai	obfuscated obfuscation